4//SEC Filing
HAUSMAN DIANA 4
Accession 0001725160-23-000116
CIK 0001725160other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:13 AM ET
Size
5.2 KB
Accession
0001725160-23-000116
Insider Transaction Report
Form 4
HAUSMAN DIANA
Director
Transactions
- Award
Common Stock
2023-05-08+39,732→ 39,732 total
Footnotes (1)
- [F1]The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001563992
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 7:13 AM ET
- Size
- 5.2 KB